The Respiratory Equipment industry trends over the past 18 months reflect accelerated innovation driven by rising demand for remote patient monitoring and chronic disease management. Strategic partnerships have shaped the landscape, with firms like ResMed collaborating with telehealth platforms to integrate AI-driven analytics into CPAP devices, enhancing patient adherence tracking. In Mergers & acquisitions, Koninklijke Philips acquired a U.S.-based digital health startup specializing in predictive respiratory analytics, consolidating its position in smart inhaler technology. Regulatory bodies, including the FDA, have prioritized expedited approvals for non-invasive ventilation systems, responding to surges in sleep apnea and post-COPD care needs. Meanwhile, product/technology launches highlight a shift toward wearable, data-connected devices, such as portable oxygen concentrators with cloud-based health dashboards. Consumer demand is increasingly favoring home-based solutions, fueled by telehealth adoption, while enterprises invest in scalable, interoperable systems for hospital-at-home models. Notably, a $150M funding round secured by a European startup in 2023 underscores investor confidence in next-gen, AI-powered diagnostics for early-stage pulmonary disease detection.
